
May 16, 2023
Babette’s Cancer Journey: Remarkable Progress and a Future in Sight
Babette’s journey with Immunocine is progressing steadily, and we’re excited to bring you another update on her path to recovery. Now nearly five months after completing her treatment, Babette continues to work with the Immunocine Team, who evaluate her medical reports and scans to closely to provide feedback. Since completing her treatment, Babette’s health improvements […]
Read moreMarch 15, 2023
Boosting Immunotherapy with Dietary Fiber
Of the 1.9 million cancer patients in 2021, 600,000 received immunotherapy, a remarkable number given the FDA approved the first cancer immunotherapy in 2011. This growth in the utilization of immunotherapy has spurred research into novel immunotherapies such as Immunocine’s Treatment, but also in supportive approaches to enhance immunotherapy. While it’s promising that there is […]
Read moreMarch 12, 2023
Diet Guide to Prepare for Immunotherapy
As cancer patients prepare to come to Cancun to begin their personalized Immunotherapy journey, they often ask if there are things they can do to “improve the odds of success.” And while there are a few things, the focus here will be on diet and how it could improve the response of the Immunocine Therapy. […]
Read moreFebruary 10, 2023
Immunocine Dendritic Cell Therapy for Colorectal Cancers
Colorectal cancers have been on the rise and now afflict more than 2 million humans per year, more than 150,000 Americans per year1, and is simultaneously becoming one of the deadliest cancer categories across genders2, 3. In a room with 50 people, it is a sobering reality to understand that 3-5 of them will have […]
Read moreFebruary 9, 2023
Dendritic Cells and Their Therapeutic Role in Prostate Cancer
In 2022, almost 270,000 American men will be diagnosed with prostate cancer, and about 35,000 prostate cancer patients will succumb to the disease. Metastasized prostate cancer leaves only a 31% chance of a 5-year survival, and to date, prostate cancer is the 2nd leading cause of cancer-related death in men1. This disease continues to beg […]
Read moreJanuary 2, 2023
Babette’s Treatment Update
Babette has finally completed treatment at Immunocine. Now back home, the Immunocine Team will stay in contact with her to evaluate any future medical reports and scans. These follow ups are critical to ensure her physicians know what to expect going forward and Babette’s Immune System continues to attack her cancer. With her treatment complete, Babette kindly volunteered […]
Read moreDecember 20, 2022
Why Is Immunocine in Cancun, Mexico?
Why isn’t Immunocine Cancer Treatment in the US? Alternative treatment centers are often met with a skeptical eye, and with justifiable reason. Though many take issue with how lengthy the FDA approval process is, the reality is that without it, there is no real way to determine the veracity of many of the claims out […]
Read moreDecember 2, 2022
Babette’s Treatment Experience with Immunocine
Many of our patients are pleasantly surprised by how much they enjoy their time in Cancun. While our team is more than happy to provide our perspective on what to expect, we know that first hand experience is hard to beat! Having arrived last month to start her treatment, Immunocine patient Babette Lamarre kindly volunteered […]
Read moreNovember 19, 2022
What Is Immunotherapy?
In the late 1800’s Dr. William Coley stumbled onto an interesting observation, that an active immune response in the area of a tumor could delay and even occasionally eliminate a cancerous threat1, 2. Though he didn’t fully understand the mechanisms at that time, he essentially demonstrated the power of the immune system even against a […]
Read moreNovember 16, 2022
Is Alternative Cancer Treatment Safe and Effective?
As we now live in an age in which information freely flows and all manners of hyperbole are available at our fingertips through our screens, it is hard to know what is “real” and what is “fake.” Patients that receive a cancer diagnosis often find themselves scouring the corners of the internet attempting to find […]
Read moreOctober 21, 2022
Cancer Cells Hiding in Other Cancer Cells?
As we outlined in our post dedicated to Head & Neck Cancer, the Immune System has the inherent ability to find and destroy cancer cells. In fact, it does this for you every day! Since humans already have this natural ability, scientists are continually researching why cancer cells are able to avoid detection and ultimately grow […]
Read moreOctober 11, 2022
The Misconception of Checkpoint Inhibitors
Checkpoint Inhibitor's early success and their ease have resulted in widespread use as a cancer treatment. However, this popularity has resulted in many cancer patients believing that Checkpoint Inhibitors represent all of Immunotherapy.
Read moreSeptember 19, 2022
Understanding Immunotherapy with World Renowned Author, Haylie Pomroy
The Immunocine Team’s Dr. Matt Halpert and Dr. Rafael Gonzalez recently recorded a podcast with #1 NYT Best Selling Author and Celebrity Nutritionist, Haylie Pomroy. Seeking to provide more information about Immunotherapy as a cancer treatment for her community, Haylie and our team covered the basics of Immunotherapy, why Immunotherapy has so much potential, and […]
Read moreAugust 24, 2022
Stage 4 Prostate Cancer Patient Update after 5 Years
In 2014, Chris had Stage 4 Metastatic Prostate Cancer that had spread throughout his body. After learning about Dr. Halpert's Dendritic Cell Research at the Houston Medical Center, Chris was one of the first patient's to receive an earlier version of Immunocine's Dendritic Cell Treatment.
Read moreJuly 26, 2022
Using Dendritic Cells to Fight Head and Neck Cancers
HNC is the 6th most common cancer in the world with roughly 550,000 diagnoses each year. Researchers have recently uncovered what they believe is the secret weapon of Head and Neck Cancers. Fortunately, Immunocine's cancer treatment unique process is able to overcome HNC's ability to avoid Immune System detection.
Read moreJuly 11, 2022
Advances in Treating Triple-Negative Breast Cancer
Triple-negative breast cancer is a unique form of breast cancer lacking in typical receptors found on these breast cells. Despite its difficulty in treating, the Immunocine Cancer Center's treatment has had demonstrated success in treating triple-negative cancer patients.
Read moreJune 24, 2022
A Revolutionary Approach to Cancer Treatments
ImmunoCine's Dendritic Cell Treatment represents a huge step forward in Immunotherapy and utilizing Dendritic Cells to fight cancer. This blog post covers how this is possible with ImmunoCine's unique treatment.
Read moreMay 25, 2022
Preparing for Your Trip and Treatment
It’s time to fight this cancer, fight it on your terms, and fight it hard. How should you prepare? The medical intervention will be overseen by the ImmunoCine Therapeutics medical team, a team of highly qualified doctors such as oncologists and interventional radiologists.
Read moreMay 25, 2022
Is this therapy available in the US?
With the variety of treatment options in the US, you may wonder why you can’t get our treatment option in the US right now. Why isn’t it available at my local hospital? Someday it most likely will be broadly available in the US, but unfortunately it is not now.
Read moreMarch 14, 2022
Your Immune System Can Fight Cancer
Each day of our lives, our immune system demonstrates its power as the greatest defense program ever created. Without it, you would not be here reading this today.
Read more